Literature DB >> 942914

Effects of parathormone and calcitonin on citrate and hyaluronate metabolism in cultured bone.

R A Luben, D V Cohn.   

Abstract

Two metabolic correlates of parathormone-induced bone resorption are increased synthesis of hyaluronate and decreased production of CO2 from citrate. We have examined these phenomena simultaneously with calcium release in cultured mouse calvaria and fetal rat radii and ulnae treated with parathormone and calcitonin, separately or in combination. In both types of tissue the parathormone dose-response curves for inhibition of citrate decarboxylation, enhanced hyaluronate synthesis, and increased release of calcium were identical when measured 48 h after treatement. In each case a minimum response occurred at approximately 0.01 mug parathormone per ml and a maximum response at about 0.1 mug per ml. The time courses of these responses to parathromone were different. Hyaluronate synthesis increased within 1 h after treatment and peaked at 6 h; decarboxylation of citrate declined after 3 h; demineralization of the bone was not detected until 24 h. When parathormone-treated bones were placed in parathormone-free medium, citrate decarboxylation returned to control levels within 24 h, but increased synthesis of hyaluronate and demineralization persisted for at least 24 h more. When calcitonin was added to bones which were treated with parathormone, the parathormone-induced inhibition of citrate metabolism did not change, but both hyaluronate synthesis and demineralization rapidly declined. Subsequently the rate of hyaluronate synthesis increased, and this was followed several hours later by an increase in demineralization. These data suggest that citrate and hyaluronate metabolism are involved in the overall response of bone to parathormone but are only loosely coupled to one another. Synthesis of hyaluronate appears to be more closely related to subsequent calcium release than is citrate metabolism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 942914     DOI: 10.1210/endo-98-2-413

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  13 in total

1.  Effects of osteoclast activating factor from human lymphocytes on cyclic AMP concentrations in isolated mouse bone and bone cells.

Authors:  R A Luben; M C Chen; D M Rosen; M A Mohler
Journal:  Calcif Tissue Int       Date:  1979-08-24       Impact factor: 4.333

2.  Local effects of impaired mechanical properties of collagen on bone formation and resorption.

Authors:  A Kwong-Hing; R Teasdale; H S Sandhu
Journal:  Anat Embryol (Berl)       Date:  1991

3.  Effects of parathyroid hormone on odontogenesis of the mouse embryonic molar tooth in vitro.

Authors:  Y Sakakura
Journal:  Calcif Tissue Int       Date:  1987-01       Impact factor: 4.333

4.  Secretory products of breast cancer cells upregulate hyaluronan production in a human osteoblast cell line.

Authors:  Nandita Bose; Anna M Masellis
Journal:  Clin Exp Metastasis       Date:  2006-04-27       Impact factor: 5.150

5.  Synthesis of hyaluronic acid by rat osteogenic sarcoma cells in culture.

Authors:  R A Melick; S Mercuri; P J Bingham
Journal:  Calcif Tissue Res       Date:  1977-05

6.  Evidence for two pathways for stimulation of collagenolysis in bone.

Authors:  R L Jilka; J W Hamilton
Journal:  Calcif Tissue Int       Date:  1985-05       Impact factor: 4.333

7.  Plasma Citrate Homeostasis: How It Is Regulated; And Its Physiological and Clinical Implications. An Important, But Neglected, Relationship in Medicine.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  HSOA J Hum Endocrinol       Date:  2016-12-31

8.  Morphological and functional characteristics of human temporal-bone cell cultures.

Authors:  M Maurizi; L Binaglia; E Donti; F Ottaviani; G Paludetti; G Venti Donti
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

9.  Production of hybridomas secreting monoclonal antibodies against the lympholine osteoclast activating factor.

Authors:  R A Luben; M A Mohler; G E Nedwin
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

10.  A macromolecular inhibitor of in vitro calcification of tendon matrix.

Authors:  C Quittner; C L Wadkins
Journal:  Calcif Tissue Res       Date:  1978-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.